Cognitive impairment in bipolar disorder: An overview

Postgraduate Medicine

Volumn 122, Issue 4, 2010, Pages 7-16

  Manove, Emily ^a   Levy, Boaz ^a  

^a UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

Author keywords

Bipolar disorder; Cognitive impairment; Psychosocial disability; Treatment

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; BRAIN DERIVED NEUROTROPHIC FACTOR; NEUROLEPTIC AGENT; LITHIUM DERIVATIVE; TRANQUILIZER;

ANXIETY; ARTICLE; BIPOLAR DISORDER; BRAIN REGION; CLINICAL ASSESSMENT; COGNITION; COGNITIVE DEFECT; COGNITIVE THERAPY; DISEASE CLASSIFICATION; DISEASE COURSE; ELECTROENCEPHALOGRAM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INTELLIGENCE QUOTIENT; NERVE CELL DIFFERENTIATION; NERVE DEGENERATION; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT; PATIENT CARE; PSYCHOTHERAPY; RISK ASSESSMENT; RISK FACTOR; SOCIAL PSYCHOLOGY; ANXIETY DISORDER; METHODOLOGY; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; REVIEW;

ANTIMANIC AGENTS; ANXIETY DISORDERS; BIPOLAR DISORDER; COGNITION DISORDERS; HUMANS; LITHIUM COMPOUNDS; NEUROPSYCHOLOGICAL TESTS; PSYCHOTHERAPY; RISK FACTORS;

EID: 77956626001     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2010.07.2170     Document Type: Article

References (101)

1. Bonnín CM, Martínez-Arán A, Torrent C, et al. Clinical and neurocognitive predictors of functional outcome in bipolar euthymic patients: a long-term, follow-up study. J Affect Disord. 2010;121:156-160.
2. Murray CL, Lopez AD. Evidence-based health policy-lessons from the Global Burden of Disease Study. Science. 1996;274:740-743.
3. Kraepelin E. Manic Depressive Insanity and Paranoia. Translated by Barclay RM; Robertson GM, ed. New York, NY: Arno Press; 1976 (originally published 1921).
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
5. Goldberg JF, Harrow M, Grossman LS. Course and outcome in bipolar affective disorder: a longitudinal follow-up study. Am J Psychiatry. 1995;152(3):379-384.
6. DelBello MP, Hanseman D, Adler CM, Fleck DE, Strakowski SM. Twelve-month outcome of adolescents with bipolar disorder following first hospitalization for a manic or mixed episode. Am J Psychiatry. 2007;164(4):582-590.
7. Goldberg JF, Burdick KE. Cognitive dysfunction in bipolar disorder: a guide for clinicians. Arlington, VA: American Psychiatric Publishing, Inc.; 2008.
8. Martinez-Aran A, Vieta E, Torrent C, et al. Functional outcome in bipolar disorder: the role of clinical and cognitive factors. Bipolar Disord. 2007;9(1-2):103-113.
9. Torres IJ, Defreitas VG, Defreitas CM, et al. Neurocognitive functioning in patients with bipolar I disorder recently recovered from a first manic episode [published online ahead of print March 23, 2010]. J Clin Psychiatry.
10. Martinez-Aran A, Vieta E, Colom F, et al. Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome. Bipolar Disord. 2004;6(3):224-232.
11. Martinez-Aran A, Vieta E, Reinares M, et al. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry. 2004;161(2):262-270.
12. Malhi GS, Ivanovski B, Hadzi-Pavlovic D, Mitchell PB, Vieta E, Sachdev P. Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia. Bipolar Disord. 2007;9 (1-2):114-125.
13. Torres IJ, Boudreau VG, Yatham LN. Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis. Acta Psychiatr Scand Suppl. 2007;434:17-26.
14. Kurtz MM, Gerraty RT. A meta-analytic investigation of neurocognitive deficits in bipolar illness: profile and effects of clinical state. Neuropsychology. 2009;23(5):551-562.
15. Trivedi JK, Dhyani M, Sharma S, Sinha PK, Singh AP, Tandon R. Cognitive functions in euthymic state of bipolar disorder: an Indian study. Cogn Neuropsychiatry. 2008;13(2):135-147.
16. Delaloye C, Moy G, Baudois S, et al. Cognitive features in euthymic bipolar patients in old age. Bipolar Disord. 2009;11(7):735-743.
17. Arnone D, Cavanagh J, Gerber D, Lawrie SM, Ebmeier KP, McIntosh AM. Magnetic resonance imaging studies in bipolar disorder and schizophrenia: meta-analysis. Br J Psychiatry. 2009;195(3): 194-201.
18. Brambilla P, Glahn DC, Balestrieri M, Soares JC. Magnetic resonance findings in bipolar disorder. Psychiatr Clin North Am. 2005;28(2): 443-467.
19. Goodwin GM, Martinez-Aran A, Glahn DC, et al. Cognitive impairment in bipolar disorder: neurodevelopment or neurodegeneration? An ECNP expert meeting report. Eur Neuropsychopharmacol. 2008;18(11): 787-793.
20. McDonald C, Zanelli J, Rabe-Hesketh S, et al. Meta-analysis of magnetic resonance imaging brain morphometry studies in bipolar disorder. Biol Psychiatry. 2004;56(6):411-417.
21. Townsend J, Bookheimer SY, Foland-Ross LC, Sugar CA, Altshuler LL. fMRI abnormalities in dorsolateral prefrontal cortex during a working memory task in manic, euthymic and depressed bipolar subjects. Psychiatry Res. 2010;182(1):22-29.
22. Bruno SD, Papadopoulou K, Cercignani M, Cipolotti L, Ron MA. Structural brain correlates of IQ changes in bipolar disorder. Psychol Med. 2006;36(5):609-618.
23. Moorhead TW, McKirdy J, Sussmann JE, et al. Progressive gray matter loss in patients with bipolar disorder. Biol Psychiatry. 2007;62(8): 894-900.
24. Langan C, McDonald C. Neurobiological trait abnormalities in bipolar disorder. Mol Psychiatry. 2009;14(9):833-846.
25. Mahon K, Burdick KE, Szeszko PR. A role for white matter abnormalities in the pathophysiology of bipolar disorder. Neurosci Biobehav Rev. 2010;34(4):533-554.
26. Kapczinski F, Vieta E, Andreazza AC, et al. Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev. 2008;32(4):675-692.
27. Cavanagh JT, Van Beck M, Muir W, et al. Case-control study of neurocognitive function in euthymic patients with bipolar disorder: an association with mania. Br J Psychiatry. 2002;180:320-326.
28. Clark L, Iversen SD, Goodwin GM. Sustained attention deficit in bipolar disorder. Br J Psychiatry. 2002;180:313-319.
29. Robinson LJ, Thompson JM, Gallagher P, et al. A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J Affect Disord. 2006;93(1-3):105-115.
30. Torres IJ, Boudreau VG, Yatham LN. Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis. Acta Psychiatr Scand Suppl. 2007;434:17-26.
31. Denicoff KD, Ali SO, Mirsky AF, et al. Relationship between prior course of illness and neuropsychological functioning in patients with bipolar disorder. J Affect Disord. 1999;56(1):67-73.
32. Robinson LJ, Ferrier IN. Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence. Bipolar Disord. 2006;8(2):103-116.
33. McEwen BS, Wingfield JC. The concept of allostasis in biology and biomedicine. Horm Behav. 2003;43(1):2-15.
34. Fagiolini A, Frank E, Scott JA, Turkin S, Kupfer DJ. Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord. 2005;7(5):424-430.
35. McIntyre RS, McElroy SL, Konarski JZ, et al. Substance use disorders and overweight/obesity in bipolar I disorder: preliminary evidence for competing addictions. J Clin Psychiatry. 2007;68(9):1352-1357.
36. Pavuluri MN, West A, Hill SK, Jindal K, Sweeney JA. Neurocognitive function in pediatric bipolar disorder: 3-year follow-up shows cognitive development lagging behind healthy youths. J Am Acad Child Adolesc Psychiatry. 2009;48(3):299-307.
37. Kolur US, Reddy YC, John JP, Kandavel T, Jain S. Sustained attention and executive functions in euthymic young people with bipolar disorder. Br J Psychiatry. 2006;189:453-458.
38. Terry J, Lopez-Larson M, Frazier JA. Magnetic resonance imaging studies in early onset bipolar disorder: an updated review. Child Adolesc Psychiatr Clin N Am. 2009;18(2):421-439, ix-x.
39. Vita A, De Peri L, Sacchetti E. Gray matter, white matter, brain, and intracranial volumes in first-episode bipolar disorder: a meta-analysis of magnetic resonance imaging studies. Bipolar Disord. 2009;11(8):807-814.
40. Strakowski SM, Delbello MP, Adler CM. The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Mol Psychiatry. 2005;10(1):105-116.
41. Cannon M, Jones P, Gilvarry C, et al. Premorbid social functioning in schizophrenia and bipolar disorder: similarities and differences. Am J Psychiatry. 1997;154(11):1544-1550.
42. Reichenberg A, Weiser M, Rabinowitz J, et al. A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder. Am J Psychiatry. 2002;159(12):2027-2035.
43. Zammit S, Allebeck P, David AS, et al. A longitudinal study of premorbid IQ Score and risk of developing schizophrenia, bipolar disorder, severe depression, and other nonaffective psychoses. Arch Gen Psychiatry. 2004;61(4):354-360.
44. Bora E, Yucel M, Pantelis C. Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. J Affect Disord. 2009;113(1-2):1-20.
45. Gruber SA, Rosso IM, Yurgelun-Todd D. Neuropsychological performance predicts clinical recovery in bipolar patients. J Affect Disord. 2008;105(1-3):253-560.
46. Joseph MF, Frazier TW, Youngstrom EA, Soares JC. A quantitative and qualitative review of neurocognitive performance in pediatric bipolar disorder. J Child Adolesc Psychopharmacol. 2008;18(6):595-605.
47. Mur M, Portella MJ, Martínez-Arán A, Pifarré J, Vieta E. Persistent neuropsychological deficit in euthymic bipolar patients: executive function as a core deficit. J Clin Psychiatry. 2007;68(7):1078-1086.
48. Tiihonen J, Haukka J, Henriksson M, et al. Premorbid intellectual functioning in bipolar disorder and schizophrenia: results from a cohort study of male conscripts. Am J Psychiatry. 2005;162(10):1904-1910.
49. Arts B, Jabben N, Krabbendam L, van Os J. Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives. Psychol Med. 2008;38(6):771-785.
50. Balanzá-Martínez V, Rubio C, Selva-Vera G, et al. Neurocognitive endophenotypes (endophenocognitypes) from studies of relatives of bipolar disorder subjects: a systematic review. Neurosci Biobehav Rev. 2008;32(8):1426-1438.
51. Frantom LV, Allen DN, Cross CL. Neurocognitive endophenotypes for bipolar disorder. Bipolar Disord. 2008;10(3):387-399.
52. Mirakhur A, Moorhead TW, Stanfield AC, et al. Changes in gyrification over 4 years in bipolar disorder and their association with the brain-derived neurotrophic factor valine(66) methionine variant. Biol Psychiatry. 2009;66(3):293-297.
53. Lee JH, Dunner DL. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders. Depress Anxiety. 2008;25(2): 91-97.
54. Simon NM, Otto MW, Wisniewski SR, et al. Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry. 2004;161(12):2222-2229.
55. Freeman MP, Freeman SA, McElroy SL. The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues. J Affect Disord. 2002;68(1):1-23.
56. Goldstein BI, Levitt AJ. The specific burden of comorbid anxiety disorders and of substance use disorders in bipolar I disorder. Bipolar Disord. 2008;10(1):67-78.
57. Baldassano CF. Illness course, comorbidity, gender, and suicidality in patients with bipolar disorder. J Clin Psychiatry. 2006;67 (suppl 11):8-11.
58. Boylan KR, Bieling PJ, Marriott M, Begin H, Young LT, MacQueen GM. Impact of comorbid anxiety disorders on outcome in a cohort of patients with bipolar disorder. J Clin Psychiatry. 2004;65(8):1106-1113.
59. Coryell W, Solomon DA, Fiedorowicz JG, Endicott J, Schettler PJ, Judd LL. Anxiety and outcome in bipolar disorder. Am J Psychiatry. 2009;166(11):1238-1243.
60. El-Mallakh RS, Hollifield M. Comorbid anxiety in bipolar disorder alters treatment and prognosis. Psychiatr Q. 2008;79(2):139-150.
61. Henry C, Van den Bulke D, Bellivier F, Etain B, Rouillon F, Leboyer M. Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer. J Clin Psychiatry. 2003;64(3):331-335.
62. McElroy SL, Altshuler LL, Suppes T, et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry. 2001;158(3):420-426.
63. Silva LT, Leite JR. Physiological modifications and increase in state anxiety in volunteers submitted to the Stroop Color-Word Interference Test: A preliminary study. Physiol Behav. 2000;70(1-2):113-118.
64. Fertuck EA, Marsano-Jozefowicz S, Stanley B, et al. The impact of borderline personality disorder and anxiety on neuropsychological performance in major depression. J Pers Disord. 2006;20(1):55-70.
65. Fishbein D, Hyde C, Eldreth D, et al. Cognitive performance and autonomic reactivity in abstinent drug abusers and nonusers. Exp Clin Psychol. 2005;13:25-40.
66. Kobayashi N, Yoshino A, Takahashi Y, Nomura S. Autonomic arousal in cognitive conflict resolution. Auton Neurosci. 2007;132(1-2):70-75.
67. Duschek S, Muckenthaler M, Werner N, del Paso GA. Relationships between features of autonomic cardiovascular control and cognitive performance. Biol Psychol. 2009;81(2):110-117.
68. Beaudreau SA, O'Hara R. The association of anxiety and depressive symptoms with cognitive performance in community-dwelling older adults. Psychol Aging. 2009;24(2):507-512.
69. Lee BK, Glass TA, McAtee MJ, et al. Associations of salivary cortisol with cognitive function in the Baltimore memory study. Arch Gen Psychiatry. 2007;64(7):810-818.
70. Miu AC, Heilman RM, Houser D. Anxiety impairs decision-making: psychophysiological evidence from an Iowa Gambling Task. Biol Psychol. 2008;77(3):353-358.
71. Schwerdtfeger A. Trait anxiety and autonomic indicators of the processing of threatening information: a cued S1-S2 paradigm. Biol Psychol. 2006;72(1):59-66.
72. Knapman A, Heinzmann JM, Hellweg R, et al. Increased stress reactivity is associated with cognitive deficits and decreased hippocampal brain-derived neurotrophic factor in a mouse model of affective disorders. J Psychiatr Res. 2010;44(9):566-575.
73. Touma C, Bunck M, Glasl L, et al. Mice selected for high versus low stress reactivity: a new animal model for affective disorders. Psychoneuroendocrinology. 2008;33(6):839-862.
74. Daban C, Vieta E, Mackin P, Young A. Hypothalamic-pituitary-adrenal axis and bipolar disorder. Psychiatr Clin North Am. 2005;28(2): 469-480.
75. Martinez-Aran A, Vieta E, Colom F, et al. Do cognitive complaints in euthymic bipolar patients reflect objective cognitive impairment? Psychother Psychosom. 2005;74(5):295-302.
76. Sanchez-Moreno J, Martinez-Aran A, Tabarés-Seisdedos R, Torrent C, Vieta E, Ayuso-Mateos JL. Functioning and disability in bipolar disorder: an extensive review. Psychother Psychosom. 2009;78(5):285-297.
77. Dickerson F, Origoni A, Stallings C, Khushalani S, Dickinson D, Medoff D. Occupational status and social adjustment six months after hospitalization early in the course of bipolar disorder: a prospective study. Bipolar Disord. 2010;12(10):10-20.
78. Jaeger J, Berns S, Loftus S, et al. Neurocognitive test performance predicts functional recovery from acute exacerbation leading to hospitalization in bipolar disorder. Bipolar Disord. 2007;9(1-2):93-102.
79. Martino DJ, Marengo E, Igoa A, et al. Neurocognitive and symptomatic predictors of functional outcome in bipolar disorders: a prospective 1 year follow-up study. Affect Disord. 2009;116(1-2):37-42.
80. Mur M, Portella MJ, Martínez-Arán A, Pifarré J, Vieta E. Long-term stability of cognitive impairment in bipolar disorder: a 2-year follow-up study of lithium-treated euthymic bipolar patients. J Clin Psychiatry. 2008;69(5):712-719.
81. Mur M, Portella MJ, Martínez-Arán A, Pifarré J, Vieta E. Neuropsychological profile in bipolar disorder: a preliminary study of monotherapy lithium-treated euthymic bipolar patients evaluated at a 2-year interval. Acta Psychiatr Scand. 2008;118(5):373-381.
82. Mur M, Portella MJ, Martinez-Aran A, Pifarre J, Vieta E. Influence of clinical and neuropsychological variables on the psychosocial and occupational outcome of remitted bipolar patients. Psychopathology. 2009;42(3):148-156.
83. Tabarés-Seisdedos R, Balanzá-Martínez V, Sánchez-Moreno J, et al. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up. J Affect Disord. 2008;109(3):286-299.
84. Brissos S, Dias VV, Carita AI, Martinez-Arán A. Quality of life in bipolar type I disorder and schizophrenia in remission: clinical and neurocognitive correlates. Psychiatry Res. 2008;160(1):55-62.
85. Brissos S, Dias VV, Kapczinski F. Cognitive performance and quality of life in bipolar disorder. Can J Psychiatry. 2008;53(8): 517-524.
86. Hosang GM, Korszun A, Jones L, et al. Adverse life event reporting and worst illness episodes in unipolar and bipolar affective disorders: measuring environmental risk for genetic research [published online ahead of print February 5, 2010]. Psychol Med.
87. Hosang GM, Uher R, Keers R, et al. Stressful life events and the brain-derived neurotrophic factor gene in bipolar disorder [published online ahead of print February 19, 2010]. J Affect Disord.
88. Sylvia LG, Alloy LB, Hafner JA, et al. Life events and social rhythms in bipolar spectrum disorders: a prospective study. Behav Ther. 2009;40(2):131-141.
89. Cohen AN, Hammen C, Henry RM, et al. Effects of stress and social support on recurrence in bipolar disorder. J Affect Disord. 2004;82(1): 143-147.
90. Levy B, Monzani BA, Stephansky MR, Weiss RD. Neurocognitive impairment in patients with co-occurring bipolar disorder and alcohol dependence upon discharge from inpatient care. Psychiatry Res. 2008;161(1):28-35.
91. Levy B, Stephansky MR, Dobie KC, et al. The duration of inpatient admission predicts cognitive functioning at discharge in patients with bipolar disorder. Compr Psychiatry. 2009;50(4):322-326.
92. Norman LR, Basso M, Kumar A, Malow R. Neuropsychological consequences of HIV and substance abuse: a literature review and implications for treatment and future research. Curr Drug Abuse Rev. 2009;2(2):143-156.
93. Grohman K, Fals-Stewart W, Donnelly K. Improving treatment response of cognitively impaired veterans with neuropsychological rehabilitation. Brain Cogn. 2006;60(2):203-204.
94. Deckersbach T, Nierenberg AA, Kessler R, et al. Cognitive rehabilitation for bipolar disorder: an open trial for employed patients with residual depressive symptoms [published online ahead of print November 9, 2009]. CNS Neurosci Ther.
95. López-Jaramillo C, Lopera-Vásquez J, Ospina-Duque J, et al. Lithium treatment effects on the neuropsychological functioning of patients with bipolar I disorder [published online ahead of print March 23, 2010]. J Clin Psychiatry.
96. Wingo AP, Wingo TS, Harvey PD, Baldessarini RJ. Effects of lithium on cognitive performance: a meta-analysis. J Clin Psychiatry. 2009;70(11):1588-1597.
97. Foland LC, Altshuler LL, Sugar CA, et al. Increased volume of the amygdala and hippocampus in bipolar patients treated with lithium. Neuroreport. 2008;19(2):221-224.
98. Lyoo IK, Dager SR, Kim JE, et al. Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: a longitudinal brain imaging study [published online ahead of print March 31, 2010]. Neuropsychopharmacology.
99. Moore GJ, Cortese BM, Glitz DA, et al. A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients. J Clin Psychiatry. 2009;70(5):699-705.
100. Jamrozinski K, Gruber O, Kemmer C, Falkai P, Scherk H. Neurocognitive functions in euthymic bipolar patients. Acta Psychiatr Scand. 2009;119(5):365-374.
101. Goldberg JF, Chengappa KN. Identifying and treating cognitive impairment in bipolar disorder. Bipolar Disord. 2009;11(suppl 2): 123-137.